Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2025-12-31 @ 9:31 AM
Study NCT ID:
NCT01024504
Status:
COMPLETED
Last Update Posted:
2010-04-09
First Post:
2009-11-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer
Sponsor:
Hellenic Oncology Research Group
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CT/06.12
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
John Souglakos
Old Organization:
University Hospital of Crete
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |